Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) CEO

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
420
Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) CEO Outlines the Benefits, Capabilities of its HealthTab(TM) Platform in a Recent PBA à Noon Podcast Episode

- Avricore recently launched HealthTab, its point-of-care testing platform, in 12 Shoppers Drug Mart stores as well as in several independent pharmacies in Canada
- Speaking in a recent PBA à Noon podcast, Avricore CEO Hector Bremner outlined several benefits and capabilities of the platform
- HealthTab processes patients’ diagnostics and biometric data to generate easy-to-read personalized reports that patients and professionals can use to guide care plans
- It can also power third-party health tech products with real-world results and diagnostics as it is built on an open API platform

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is disrupting and revolutionizing the pharmacy practice through its proprietary solution that combines various novel elements and enables users to enjoy a plethora of benefits at a lower cost. This was part of the message company CEO Hector Bremner delivered during a recent PBA à Noon podcast episode hosted by Paul Benwell & Associates (https://nnw.fm/mdr8r).

Bremner was describing Avricore’s point-of-care testing platform, HealthTab(TM), which was recently launched in 15 Shoppers Drug Mart stores located in the Greater Toronto Area and in several independent pharmacies in British Columbia and Ontario (https://nnw.fm/7mbkb).

“HealthTab sources the best point-of-care analyzers and brings them onto a single, secure cloud-based network. It gives patients and pharmacies access to results on the spot and makes de-identified data available in real-time. This harmonized model for community-based testing is the first of its kind, making Avricore the clear leader in this rapidly emerging space,” reads the company’s presentation (https://nnw.fm/40TGO).

In describing exactly what HealthTab is, Bremner delineated the platform’s functionality. Everything begins when the patient provides consent and answers a customized health survey when creating an account, either online or within the store. While at the store, the integrated on-site lab-accurate testing device collects the patient’s diagnostics information. The HealthTab system then merges the data from the survey and testing device, processes it using complex calculations to filter the biometric and diagnostic data of the patient, and then generates personalized reports.

“And so, the power of HealthTab is that it is able to greatly reduce the amount of administration time, extract the result directly out of the machine, merge information, do the complex calculations in order to properly interpret the data, and then produce it in an easy to read format that the patient and professional can interpret quickly and understand the result and then use that to guide their care plan,” Bremner continued.

In addition to these benefits and capabilities, HealthTab boasts a de-identified real-time data attribute that can enable researchers, drug makers, governments, and NGOs to use the platform to conduct studies and research in real-time, real-world settings in community pharmacies. Although de-identification, while desirable, is not a new concept, it is done on an ad hoc basis, according to Bremner.

“It’s been largely due to lack of infrastructure and the type and costing of that type of testing that has been available to them in the pharmacy,” explained Bremner. “However, HealthTab is the breakthrough. We’ve simplified it, made it easy, and affordable.”

Built on an open API platform, HealthTab can connect to other B2B or B2C health data-focused software. As a result, the platform, which supports easy and quick data transfers, can power third-party health tech products with real-world results and direct diagnostics from pharmacies. HealthTab also has a “fantastic interface” that allows individual patients to seamlessly navigate the platform.

Through the various features packed into HealthTab, Avricore is empowering patients along a healthier path.

For more information, visit the company’s website at www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://nnw.fm/AVCRF

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://nnw.fm/LEXX

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer


Avricore Health Inc. (AVCRF) Stock Research Links

AVCRF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

HeartCore's Journey: From Nasdaq Challenges to Growth Potential

Updated Category News Views 35

HeartCore's Nasdaq Delisting Challenge HeartCore Enterprises, Inc. (NASDAQ:HTCR), a provider of enterprise software and consulting services, is currently facing a significant challenge related to its listing on the Nasdaq Capital Market. The company has received notice of non-compliance with the minimum bid price requirement, which mandates that its stock price must be at...

Continue Reading
Mitchell Capital Expands Portfolio with Optelos Acquisition

Updated Category News Views 236

Mitchell Capital's New Acquisition of Optelos Mitchell Capital, a prominent private equity firm, recently announced a significant acquisition that marks a pivotal moment for their long-term investment strategy. They have secured a controlling interest in Optelos, a distinguished provider of digital twin platforms that are tailored for enhancing critical infrastructure...

Continue Reading
Tampa Bay Lightning and Scripps Sports Forge Exciting Partnership

Updated Category News Views 247

Partnership Announcement Between Tampa Bay Lightning and Scripps Sports The Tampa Bay Lightning have officially entered into an exciting multi-year partnership with Scripps Sports. This collaboration signifies a new chapter for the Tampa Bay Lightning, expanding their reach in broadcasting and enhancing viewer engagement with National Hockey League (NHL) games. Through...

Continue Reading
Kazia Therapeutics Sets Meeting with FDA on Glioblastoma Treatment

Updated Category News Views 61

Kazia Therapeutics Prepares for FDA Meeting on Paxalisib Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is set to meet with the U.S. Food and Drug Administration (FDA) to explore potential pathways for the registration of its innovative drug, Paxalisib, aimed at treating newly diagnosed glioblastoma multiforme (GBM). This crucial...

Continue Reading
Important Notice for Flux Power Investors on Lead Plaintiff Claims

Updated Category News Views 100

Overview of Flux Power Investor Claims Investors with concerns regarding their investments in Flux Power Holdings, Inc. (NASDAQ: FLUX) have much to consider as recent developments unfold. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims that could impact investor interests and is eager to assist those affected. Critical Investment...

Continue Reading